Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05153148 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis
A Phase 2 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 2
- Development phase
- 305
- Enrollment target
NCT05153148 is a Phase 2 study that has completed, run by Takeda. The registered enrollment target is 305 participants.
The verdict
NCT05153148, a Phase 2 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 305 participants
- Enrollment target
Study Summary
This study is designed to evaluate the efficacy, safety, and tolerability of NDI-034858 in participants with active Psoriatic Arthritis (PsA).
Interventions
- OTHER Placebo
- DRUG NDI-034858
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2022-01-06 |
| Est. Completion | 2023-06-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05153148
The ClinicalTrials.gov registry entry for NCT05153148 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05153148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05153148 about?
NCT05153148 is a clinical study titled "A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis". This study is designed to evaluate the efficacy, safety, and tolerability of NDI-034858 in participants with active Psoriatic Arthritis (PsA).
What is the current status of trial NCT05153148?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 305 participants. The study started on 2022-01-06. Estimated completion is 2023-06-02.
What interventions are being tested in trial NCT05153148?
The interventions under investigation include: Placebo (OTHER), NDI-034858 (DRUG).
Who is sponsoring clinical trial NCT05153148?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.